Legal & General Group PLC Editas Medicine, Inc. Transaction History

Legal & General Group PLC

  • $440 Billion
  • Q2 2024

A detailed history of Legal & General Group PLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 87,093 shares of EDIT stock, worth $303,083. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,093
Previous 79,428 9.65%
Holding current value
$303,083
Previous $589,000 31.07%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$4.67 - $7.28 $35,795 - $55,801
7,665 Added 9.65%
87,093 $406,000
Q1 2024

May 14, 2024
BUY
$7.03 - $11.07 $12,703 - $20,003
1,807 Added 2.33%
79,428 $589,000
Q4 2023

Feb 15, 2024
SELL
$6.25 - $11.11 $906 - $1,610
-145 Reduced 0.19%
77,621 $786,000
Q3 2023

Nov 14, 2023
BUY
$6.92 - $9.31 $56,764 - $76,369
8,203 Added 11.79%
77,766 $606,000
Q2 2023

Aug 14, 2023
SELL
$6.36 - $11.47 $639,548 - $1.15 Million
-100,558 Reduced 59.11%
69,563 $572,000
Q1 2023

May 15, 2023
BUY
$7.03 - $11.53 $105,885 - $173,664
15,062 Added 9.71%
170,121 $1.23 Million
Q4 2022

Feb 14, 2023
BUY
$8.32 - $13.21 $780,000 - $1.24 Million
93,750 Added 152.91%
155,059 $1.38 Million
Q3 2022

Nov 14, 2022
SELL
$12.16 - $19.42 $1.18 Million - $1.88 Million
-96,794 Reduced 61.22%
61,309 $750,000
Q2 2022

Aug 22, 2022
BUY
$9.99 - $21.35 $278,071 - $594,277
27,835 Added 21.37%
158,103 $1.87 Million
Q1 2022

May 16, 2022
BUY
$14.08 - $27.63 $252,581 - $495,654
17,939 Added 15.97%
130,268 $2.48 Million
Q4 2021

Feb 14, 2022
BUY
$26.55 - $40.57 $791,428 - $1.21 Million
29,809 Added 36.12%
112,329 $2.98 Million
Q3 2021

Nov 15, 2021
SELL
$39.27 - $72.94 $2 Million - $3.71 Million
-50,891 Reduced 38.15%
82,520 $3.39 Million
Q2 2021

Aug 12, 2021
BUY
$31.29 - $56.64 $466,377 - $844,219
14,905 Added 12.58%
133,411 $7.56 Million
Q1 2021

May 17, 2021
BUY
$39.71 - $90.58 $1.43 Million - $3.27 Million
36,069 Added 43.75%
118,506 $4.98 Million
Q4 2020

Feb 12, 2021
BUY
$27.07 - $84.35 $975,413 - $3.04 Million
36,033 Added 77.65%
82,437 $5.78 Million
Q3 2020

Nov 13, 2020
BUY
$28.06 - $37.16 $31,988 - $42,362
1,140 Added 2.52%
46,404 $1.3 Million
Q2 2020

Aug 14, 2020
BUY
$18.5 - $34.34 $175,583 - $325,920
9,491 Added 26.53%
45,264 $1.34 Million
Q1 2020

May 14, 2020
BUY
$14.88 - $32.78 $16,234 - $35,762
1,091 Added 3.15%
35,773 $746,000
Q4 2019

Feb 13, 2020
BUY
$19.49 - $32.63 $45,119 - $75,538
2,315 Added 7.15%
34,682 $1.03 Million
Q3 2019

Nov 13, 2019
BUY
$22.49 - $26.81 $257,555 - $307,028
11,452 Added 54.75%
32,367 $735,000
Q2 2019

Aug 14, 2019
BUY
$20.48 - $27.76 $51,404 - $69,677
2,510 Added 13.64%
20,915 $518,000
Q1 2019

May 15, 2019
BUY
$19.43 - $26.41 $4,430 - $6,021
228 Added 1.25%
18,405 $450,000
Q4 2018

Feb 15, 2019
BUY
$18.19 - $31.79 $16,116 - $28,165
886 Added 5.12%
18,177 $413,000
Q3 2018

Nov 20, 2018
BUY
$27.65 - $38.39 $278,297 - $386,395
10,065 Added 139.29%
17,291 $551,000
Q2 2018

Aug 10, 2018
BUY
$31.4 - $41.01 $7,253 - $9,473
231 Added 3.3%
7,226 $259,000
Q1 2018

May 17, 2018
SELL
$29.84 - $44.08 $36,285 - $53,601
-1,216 Reduced 14.81%
6,995 $232,000
Q4 2017

Feb 13, 2018
BUY
$21.89 - $31.34 $179,738 - $257,332
8,211
8,211 $254,000

Others Institutions Holding EDIT

# of Institutions
252
Shares Held
58.7M
Call Options Held
494K
Put Options Held
417K
View Full List

About Editas Medicine, Inc.

EDIT Quotes by TradingView
  • Ticker EDIT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 68,737,200
  • Market Cap $239M
  • Description
  • Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...
More about EDIT
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email